We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Antonio Ceriello MD, MPH

Antonio Ceriello MD, MPH

Head, Diabetes Research Program, IRCCS MultiMedica, Milan, Italy

Professor Antonio Ceriello is Research Consultant at IRCCS MultiMedica, Milan, Italy.

Professor Ceriello has published widely in the area of diabetes with over 500 original papers and with an h-index of 114. He chaired the International Diabetes Federation (IDF) committee for the development in 2008, and in the 2011 for the update of “Guideline for Management of Postmeal Glucose ”. Currently, is the President of the European Association for the Study of Diabetes (EASD) Study Group on “Diabetes and Cardiovascular Diseases”. He also served as Board member of the “2019 European Society of Cardiology (ESC) guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD “. He also served as Associate Editor of “Diabetes Care” from 2003 to 2011 and Associate Editor of “Diabetic Medicine” from 2005 to 2016. From July 1st 2016 he has been appointed as Editor in Chief of “Diabetes Research and Clinical Practice”, the official IDF journal. Currently he is also in the Editorial Board of “Cardiovascular Diabetology”. Prof. Ceriello is the winner of the 2004 “Camillo Golgi Prize” of the EASD and of the 2017 of the “Hellmut Mehnert Award”, during the IDF 2017 Meeting.

Disclosures

Professor Ceriello reports the following:
Advisory Board, Consultancy, Lectures: Astra Zeneca, Bayer, Berlin Chemie, Eli Lilly, Elsevier, Novo Nordisk, Italian Ministry of Health – Ricerca Finalizzata. Roche Diagnostics, Servier, Theras.